Local delivery of the topoisomerase I inhibitor camptothecin sodium prolongs survival in the rat intracranial 9L gliosarcoma model

International Journal of Cancer

Volumn 62, Issue 5, 1995, Pages 605-609

  Weingart, Jon D ^a   Thompson, Reid C ^a   Tyler, Betty ^a   Colvin, O Michael ^a   Brem, Henry ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN SODIUM; DNA TOPOISOMERASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; BRAIN TUMOR; CANCER GRAFT; CONTROLLED STUDY; GLIOSARCOMA; INTRAPERITONEAL DRUG ADMINISTRATION; INTRATUMORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SURVIVAL;

ANIMAL; BRAIN NEOPLASMS; CAMPTOTHECIN; DELAYED-ACTION PREPARATIONS; DNA TOPOISOMERASES, TYPE I; GLIOSARCOMA; INJECTIONS, INTRALESIONAL; MALE; POLYMERS; RATS; RATS, INBRED F344; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL ANALYSIS;

EID: 0029098633     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910620519     Document Type: Article

References (31)

1. Polymers to treat brain tumors
2. Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas
3. Intraoperatiye chemotherapy using biodegradable polymers: safety and effectiveness for recurrent glioma evaluated by a prospective, multi‐institutional placebo‐controlled clinical trial
4. Drug delivery to the brain
5. Topographic anatomy and CT correlations in the untreated glioblastoma multiforme
6. Studies on the therapeutic effectiveness of drugs with tumor weight and survival time indices of Walker 256 carcinosarcoma
7. Controlled delivery of water soluble and hydrolytically unstable anticancer drugs from polymeric implants
8. Lethal activity of camptothecin sodium on human lymphoma cells
9. Preliminary pharmacologic and clinical evaluation of camptothecin sodium (NSC‐100880)
10. Treatment of malignant melanoma with camptothecin (NSC‐100880)
11. Assumptions in the radiotherapy of glioblastoma
12. Camptothecin induces protein‐linked DNA breaks via mammalian DNA topoisom‐ erase I
13. Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin
14. Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas
15. Chemotherapy for malignant gliomas. Review article
16. New directions in CNS drug delivery
17. Biocompatibility of polymeric delivery systems for macromolecules
18. Polymers for the sustained release of proteins and other macromolecules
19. Action of camptothecin on mammalian cells in culture
20. Phase II study of camptothecin (NSC‐100880) in the treatment of advanced gastrointestinal cancer
21. Phase I clinical trial of weekly and daily treatment with camptothecin (NSC‐100880): correlation with preclinical studies
22. Camptothecins: from bench research to hospital wards
23. Polymers for sustained macromolecule release: procedure to fabricate reproducible delivery systems and control release kinetics
24. The current status of camptothecin analogues as antitumor agents
25. New natural products in cancer chemotherapy
26. Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain
27. Studies on oncolytic agents from natural sources. Correlations of activity against animal tumors and clinical effectiveness
28. Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from
29. Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma
30. The role of minocycline in treatment of intracranial 9L glioma